Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their signed agreement to take part in the study.
- People aged 18 to 70 years old (inclusive).
- People who have been diagnosed with multiple sclerosis (MS) according to a specific set of recognised diagnostic guidelines called the 2017 McDonald Criteria.
- People whose MS has caused a moderate level of disability, measured using a standard MS disability scale (EDSS score between 3.0 and 6.5), with notable weakness or movement problems in their limbs.
- People whose MS symptoms have been stable, with no relapses and no changes to symptom-related medications, for at least 30 days before the screening appointment.
- People who are already taking a medication called fampridine, provided they started it more than 30 days before screening — though starting fampridine, stimulant medications, or spasticity treatments during the study would not be permitted.
- People whose MS disease-modifying treatment has not changed in the 3 months before screening.
- People who are physically able to complete two specific walking and mobility tests used in the study, and who the trial investigator believes are willing and able to follow the study procedures.
Who may not be able to join:
- People who have another neurological condition that, in the investigator's opinion, could worsen their disability during the course of the study.
- People with significant heart, psychiatric, lung, kidney, liver, hormonal, metabolic, or digestive conditions that, in the investigator's opinion, would make participation unsafe.
- People who are pregnant, breastfeeding, or planning to become pregnant during the study.
- People who have previously received rTMS (repetitive transcranial magnetic stimulation — a type of brain stimulation therapy) for any reason.
- People who have a medical device implanted in their brain or nervous system, a pacemaker, or any other condition that makes rTMS unsafe for them.
- People who, for any other reason, the investigator considers unsuitable to participate in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francois Jacques, Neurologist, Clinique Neuro-Outaouais
Phone: 819-777-2500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Improvement of T25FWT (Timed 25-Foot Walk Test)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.